Data / Form D filings / CardioMech AS
CardioMech AS: Form D filings
CardioMech AS, a biotechnology company in Trondheim, Norway, filed 7 Form D notices with the SEC between 2019 and 2025. The latest, on April 21, 2025, reports $17.6 million sold of a $17.6 million offering to 58 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Udbyes Gate 3a, Trondheim, Norway, 7030
- Phone
- (472) 154-6100
- Industry
- Biotechnology
- Entity type
- Other (Norwegian limited liability company)
- Incorporated in
- Norway
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1768128
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | New notice | $17,560,063 | $17,560,063 | 58 | Apr 17, 2025 | sec.gov | |
| Dec 20, 2023 | New notice | $12,738,262 | $12,738,262 | 100 | Dec 20, 2023 | sec.gov | |
| Feb 21, 2023 | New notice | $4,528,164 | $4,528,164 | 38 | Feb 16, 2023 | sec.gov | |
| Apr 29, 2022 | New notice | $6,165,441 | $6,165,441 | 34 | Apr 28, 2022 | sec.gov | |
| Aug 7, 2020 | New notice | $9,200,000 | $9,200,000 | 4 | Aug 4, 2020 | sec.gov | |
| Aug 19, 2019 | New notice | $5,000,000 | $5,000,000 | 54 | Aug 12, 2019 | sec.gov | |
| Feb 19, 2019 | New notice | $2,525,000 | $2,525,000 | 39 | Feb 6, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Nehm | Executive Officer, Director | |
| Florian Eckhardt | Director | |
| Jan Habrekke | Director | |
| Vic, Jr. Bertrand | Director |
Every Form D from the week of Apr 21, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CardioMech AS reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.